EASD 2025 15 - 19 September 2025

Assessing thyroid cancer risk: GLP-1 RA shows short to intermediate-term safety

Authors :

Vanita Aroda^1,2; Tina Vilsbøll^3,4; Sune Dandanell⁵; Jens-Peter David⁵; Ceyda T P Kristiansen⁵; Fiona Roberts⁵; Michael Stellfeld⁵; Laszlo Hegedus⁶;

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Diabetes

Congress short oral presentation

GLP-1 RA

Semaglutide

Semaglutide (oral)

Liraglutide

Other